$9.57
-0.41-4.11%
At close: -
$9.57
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Bicycle Therapeutics Insider Trading Activity | NASDAQ:BCYC | Benzinga
Track the latest Bicycle Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Bicycle Therapeutics stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Bicycle Therapeutics PLC Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for Bicycle Therapeutics PLC
Shares Outstanding
69.202M
Insider Shares Owned
1.434M
Insider Percentage Owned
2.07%
Institutional Shares Held
9.112M
Institutional Percentage Held
13.2%
| Jan 06, 2025 | Alvin Travis Thompson | CHIEF ACCOUNTING OFFICER | 12.90K | $14.64 | -$67.29K | GRANT | 67.07% | 32.15K | Jan 02 - Jan 06 | View |
| Jan 06, 2025 | Alethia Young | CHIEF FINANCIAL OFFICER | 33.60K | $14.09 | -$19.66K | GRANT | 280.04% | 45.60K | Jan 02 | View |
| Jan 06, 2025 | Santiago Arroyo | CHIEF DEVELOPMENT OFFICER | 30.06K | $14.09 | -$69.65K | GRANT | 77.07% | 69.06K | Jan 02 | View |
| Jan 06, 2025 | Nigel Crockett | CHIEF BUSINESS OFFICER | 5.23K | $14.27 | -$50.20K | GRANT | 11.42% | 51.05K | Jan 02 - Jan 03 | View |
| Jan 06, 2025 | Alistair Milnes | CHIEF OPERATING OFFICER | 29.49K | $14.20 | -$78.31K | GRANT | 41.94% | 99.79K | Jan 02 - Jan 03 | View |
| Jan 06, 2025 | Michael Skynner | CHIEF TECHNOLOGY OFFICER | 30.78K | $14.24 | -$60.12K | GRANT | 33.11% | 123.72K | Jan 02 - Jan 03 | View |
| Jan 06, 2025 | Ferguson Charles Michael Hannay | CHIEF PROD & SUPPLY CHAIN OFF | 32.88K | $14.16 | -$30.00K | GRANT | 146.81% | 55.28K | Jan 02 - Jan 03 | View |
| Jan 06, 2025 | Kevin Lee | CHIEF EXECUTIVE OFFICER | 111.07K | $14.26 | -$172.95K | GRANT | 29.16% | 491.93K | Jan 02 - Jan 03 | View |
| Dec 17, 2024 | BAKER BROS ADVISORS LP LPBaker Bros Advisors GP LLCBaker Brothers Life Sciences LPFELIX BAKERJULIAN BAKER | — | 1.49M | $14.29 | $21.23M | BUY | 17.45% | 10.00M | Dec 13 - Dec 16 | View |
| Nov 13, 2024 | Alvin Travis Thompson | CHIEF ACCOUNTING OFFICER | -3.68K | $15.39 | -$142.51K | SELL | -16.06% | 19.24K | Nov 11 | View |
| Oct 04, 2024 | Kevin Lee | CHIEF EXECUTIVE OFFICER | -3.21K | $22.26 | -$71.50K | SELL | -0.84% | 380.86K | Oct 03 | View |
| Oct 04, 2024 | Ferguson Charles Michael Hannay | CHIEF PROD & SUPPLY CHAIN OFF | -247.00 | $22.26 | -$5.50K | SELL | -1.09% | 22.40K | Oct 03 | View |
| Oct 04, 2024 | Michael Skynner | CHIEF TECHNOLOGY OFFICER | -972.00 | $22.26 | -$21.64K | SELL | -1.03% | 92.94K | Oct 03 | View |
| Oct 04, 2024 | Alistair Milnes | CHIEF OPERATING OFFICER | -972.00 | $22.26 | -$21.64K | SELL | -1.36% | 70.30K | Oct 03 | View |
| Oct 04, 2024 | Nigel Crockett | CHIEF BUSINESS OFFICER | -972.00 | $22.26 | -$21.64K | SELL | -2.08% | 45.82K | Oct 03 | View |
| Oct 04, 2024 | Alvin Travis Thompson | CHIEF ACCOUNTING OFFICER | -153.00 | $22.26 | -$3.41K | SELL | -0.66% | 22.92K | Oct 03 | View |
| Jul 08, 2024 | Ferguson Charles Michael Hannay | CHIEF PROD & SUPPLY CHAIN OFF | -246.00 | $19.64 | -$4.83K | SELL | -1.07% | 22.64K | Jul 03 | View |
| Jul 08, 2024 | Michael Skynner | CHIEF TECHNOLOGY OFFICER | -967.00 | $19.64 | -$18.99K | SELL | -1.02% | 93.92K | Jul 03 | View |
| Jul 08, 2024 | Alvin Travis Thompson | CHIEF ACCOUNTING OFFICER | -148.00 | $19.64 | -$2.91K | SELL | -0.64% | 23.07K | Jul 03 | View |
| Jul 08, 2024 | Nigel Crockett | CHIEF BUSINESS OFFICER | -967.00 | $19.64 | -$18.99K | SELL | -2.02% | 46.79K | Jul 03 | View |
| Jul 08, 2024 | Nicholas Keen | CHIEF SCIENTIFIC OFFICER | -779.00 | $19.64 | -$15.30K | SELL | -1.12% | 69.02K | Jul 03 | View |
| Jul 08, 2024 | Kevin Lee | CHIEF EXECUTIVE OFFICER | -3.19K | $19.64 | -$62.73K | SELL | -0.82% | 384.08K | Jul 03 | View |
| Jul 08, 2024 | Alistair Milnes | CHIEF OPERATING OFFICER | -967.00 | $19.64 | -$18.99K | SELL | -1.34% | 71.27K | Jul 03 | View |
| Apr 12, 2024 | Ferguson Charles Michael Hannay | CHIEF PROD & SUPPLY CHAIN OFF | -257.00 | $22.49 | -$5.78K | SELL | -1.11% | 22.89K | Apr 11 | View |
| Apr 05, 2024 | Kevin Lee | CHIEF EXECUTIVE OFFICER | -3.16K | $23.81 | -$75.19K | SELL | -0.81% | 387.27K | Apr 03 | View |
| Apr 05, 2024 | Michael Skynner | CHIEF TECHNOLOGY OFFICER | -955.00 | $23.81 | -$22.74K | SELL | -1.00% | 94.88K | Apr 03 | View |
| Apr 05, 2024 | Alistair Milnes | CHIEF OPERATING OFFICER | -955.00 | $23.81 | -$22.74K | SELL | -1.30% | 72.24K | Apr 03 | View |
| Apr 05, 2024 | Nicholas Keen | CHIEF SCIENTIFIC OFFICER | -790.00 | $23.81 | -$18.81K | SELL | -1.12% | 69.80K | Apr 03 | View |
| Apr 05, 2024 | Nigel Crockett | CHIEF BUSINESS OFFICER | -955.00 | $23.81 | -$22.74K | SELL | -1.96% | 47.76K | Apr 03 | View |
| Apr 05, 2024 | Alvin Travis Thompson | CHIEF ACCOUNTING OFFICER | -152.00 | $23.81 | -$3.62K | SELL | -0.65% | 23.22K | Apr 03 | View |
| Jan 04, 2024 | Alvin Travis Thompson | CHIEF ACCOUNTING OFFICER | 15.40K | $17.50 | -$10.57K | GRANT | 192.96% | 23.38K | Jan 02 - Jan 03 | View |
| Jan 04, 2024 | Nicholas Keen | CHIEF SCIENTIFIC OFFICER | 25.36K | $17.50 | -$46.20K | GRANT | 56.07% | 70.59K | Jan 02 - Jan 03 | View |
| Jan 04, 2024 | Nigel Crockett | CHIEF BUSINESS OFFICER | 19.36K | $17.50 | -$46.25K | GRANT | 65.93% | 48.72K | Jan 02 - Jan 03 | View |
| Jan 04, 2024 | Alistair Milnes | CHIEF OPERATING OFFICER | 36.36K | $17.50 | -$46.25K | GRANT | 98.69% | 73.20K | Jan 02 - Jan 03 | View |
| Jan 04, 2024 | Michael Skynner | CHIEF TECHNOLOGY OFFICER | 25.36K | $17.50 | -$46.25K | GRANT | 35.98% | 95.84K | Jan 02 - Jan 03 | View |
| Jan 04, 2024 | Kevin Lee | CHIEF EXECUTIVE OFFICER | 68.30K | $17.50 | -$152.30K | GRANT | 21.20% | 390.43K | Jan 02 - Jan 03 | View |
| Oct 05, 2023 | Alvin Travis Thompson | CHIEF ACCOUNTING OFFICER | -54.00 | $20.00 | -$1.08K | SELL | -0.67% | 7.98K | Oct 03 | View |
| Oct 05, 2023 | Nicholas Keen | CHIEF SCIENTIFIC OFFICER | -272.00 | $20.00 | -$5.44K | SELL | -0.60% | 45.23K | Oct 03 | View |
| Oct 05, 2023 | Nigel Crockett | CHIEF BUSINESS OFFICER | -442.00 | $20.00 | -$8.84K | SELL | -1.48% | 29.36K | Oct 03 | View |
| Oct 05, 2023 | Alistair Milnes | CHIEF OPERATING OFFICER | -442.00 | $20.00 | -$8.84K | SELL | -1.19% | 36.84K | Oct 03 | View |
| Oct 05, 2023 | Kevin Lee | CHIEF EXECUTIVE OFFICER | -1.47K | $20.00 | -$29.40K | SELL | -0.45% | 322.13K | Oct 03 | View |
| Oct 05, 2023 | Michael Skynner | CHIEF TECHNOLOGY OFFICER | -442.00 | $20.00 | -$8.84K | SELL | -0.62% | 70.48K | Oct 03 | View |
| Jul 06, 2023 | Alvin Travis Thompson | CHIEF ACCOUNTING OFFICER | -61.00 | $25.10 | -$1.53K | SELL | -0.75% | 8.03K | Jul 03 | View |
| Jul 06, 2023 | Michael Skynner | CHIEF TECHNOLOGY OFFICER | -451.00 | $25.10 | -$11.32K | SELL | -0.63% | 70.92K | Jul 03 | View |
| Jul 06, 2023 | Alistair Milnes | CHIEF OPERATING OFFICER | -451.00 | $25.10 | -$11.32K | SELL | -1.20% | 37.28K | Jul 03 | View |
| Jul 06, 2023 | Kevin Lee | CHIEF EXECUTIVE OFFICER | -1.50K | $25.10 | -$37.60K | SELL | -0.46% | 323.60K | Jul 03 | View |
| Jul 06, 2023 | Nicholas Keen | CHIEF SCIENTIFIC OFFICER | -336.00 | $25.10 | -$8.43K | SELL | -0.73% | 45.51K | Jul 03 | View |
| Jul 06, 2023 | Nigel Crockett | CHIEF BUSINESS OFFICER | -451.00 | $25.10 | -$11.32K | SELL | -1.49% | 29.80K | Jul 03 | View |
| Apr 05, 2023 | Nicholas Keen | CHIEF SCIENTIFIC OFFICER | -319.00 | $21.11 | -$6.73K | SELL | -0.69% | 45.84K | Apr 03 | View |
| Apr 05, 2023 | Michael Skynner | CHIEF TECHNOLOGY OFFICER | -447.00 | $21.11 | -$9.44K | SELL | -0.62% | 71.38K | Apr 03 | View |
| Apr 05, 2023 | Alistair Milnes | CHIEF OPERATING OFFICER | -447.00 | $21.11 | -$9.44K | SELL | -1.17% | 37.73K | Apr 03 | View |
| Apr 05, 2023 | Lee Kalowski | PRESIDENT AND CFO | -376.00 | $21.11 | -$7.94K | SELL | -1.23% | 30.31K | Apr 03 | View |
| Apr 05, 2023 | Nigel Crockett | CHIEF BUSINESS OFFICER | -447.00 | $21.11 | -$9.44K | SELL | -1.46% | 30.25K | Apr 03 | View |
| Apr 05, 2023 | Lee Kalowski Attorney-in-Fact | CHIEF EXECUTIVE OFFICER | -1.49K | $21.11 | -$31.37K | SELL | -0.46% | 325.10K | Apr 03 | View |
| Jan 05, 2023 | Nigel Crockett | CHIEF BUSINESS OFFICER | 15.70K | $29.06 | -$52.34K | GRANT | 104.66% | 30.70K | Jan 03 | View |
| Jan 05, 2023 | Alistair Milnes | CHIEF OPERATING OFFICER | 15.70K | $29.06 | -$52.34K | GRANT | 69.84% | 38.18K | Jan 03 | View |
| Jan 05, 2023 | Dominic Smethurst | CHIEF MEDICAL OFFICER | 15.70K | $29.06 | -$52.34K | GRANT | 74.76% | 36.70K | Jan 03 | View |
| Jan 05, 2023 | Michael Skynner | CHIEF TECHNOLOGY OFFICER | 15.70K | $29.06 | -$52.34K | GRANT | 27.97% | 71.82K | Jan 03 | View |
| Jan 05, 2023 | Nicholas Keen | CHIEF SCIENTIFIC OFFICER | 15.68K | $29.06 | -$52.80K | GRANT | 51.46% | 46.16K | Jan 03 | View |
| Jan 05, 2023 | Lee Kalowski | PRESIDENT AND CFO | 15.69K | $29.06 | -$52.74K | GRANT | 104.57% | 30.68K | Jan 03 | View |
| Jan 05, 2023 | Lee Kalowski Attorney-in-Fact | CHIEF EXECUTIVE OFFICER | 51.50K | $29.06 | -$174.36K | GRANT | 18.72% | 326.58K | Jan 03 | View |
| Dec 22, 2021 | Pierre Legault | DIRECTOR | 0.00 | $33.08 | -$7.38M | SELL-OPTIONS | 0.00% | 0.00 | Dec 20 - Dec 22 | View |
| Oct 18, 2021 | Lee Kalowski Attorney-in-Fact | CHIEF EXECUTIVE OFFICER | -5.00K | $60.00 | -$300.02K | SELL | -2.17% | 225.09K | Oct 14 - Oct 18 | View |
| Oct 13, 2021 | Lee Kalowski Attorney-in-Fact | CHIEF EXECUTIVE OFFICER | -5.00K | $53.88 | -$269.39K | SELL | -2.13% | 230.09K | Oct 11 | View |
| Oct 05, 2021 | Nicholas Keen | CHIEF SCIENTIFIC OFFICER | -3.37K | $45.06 | -$151.69K | SELL | -100.00% | 0.00 | Oct 01 - Oct 05 | View |
| Sep 17, 2021 | Nicholas Keen | CHIEF SCIENTIFIC OFFICER | -4.96K | $45.00 | -$222.99K | SELL | -59.55% | 3.37K | Sep 15 - Sep 16 | View |
| Sep 03, 2021 | Lee Kalowski | PRESIDENT AND CFO | 0.00 | $24.91 | -$301.80K | SELL-OPTIONS | 0.00% | 0.00 | Sep 02 | View |
| Sep 03, 2021 | Nicholas Keen | CHIEF SCIENTIFIC OFFICER | -10.00K | $40.00 | -$400.00K | SELL | -54.58% | 8.32K | Sep 02 | View |
| Sep 03, 2021 | Lee Kalowski Attorney-in-Fact | CHIEF EXECUTIVE OFFICER | -9.20K | $25.82 | -$887.44K | SELL | -3.76% | 235.09K | Sep 01 - Sep 02 | View |
| Aug 31, 2021 | Lee Kalowski Attorney-in-Fact | CHIEF EXECUTIVE OFFICER | -805.00 | $25.14 | -$301.70K | SELL | -0.33% | 244.28K | Aug 27 - Aug 31 | View |
| Aug 27, 2021 | Lee Kalowski | PRESIDENT AND CFO | 0.00 | $21.94 | -$224.49K | SELL-OPTIONS | 0.00% | 0.00 | Aug 26 - Aug 27 | View |
| Aug 25, 2021 | Lee Kalowski | PRESIDENT AND CFO | 0.00 | $17.31 | -$235.65K | SELL-OPTIONS | 0.00% | 0.00 | Aug 23 | View |
| Jul 30, 2021 | Lee Kalowski | PRESIDENT AND CFO | 0.00 | $16.57 | -$373.45K | SELL-OPTIONS | 0.00% | 0.00 | Jul 29 | View |
| Jul 27, 2021 | Lee Kalowski Attorney-in-Fact | CHIEF EXECUTIVE OFFICER | 0.00 | $25.01 | -$107.50K | SELL-OPTIONS | 0.00% | 245.09K | Jul 23 - Jul 26 | View |
| Jul 16, 2021 | Nicholas Keen | CHIEF SCIENTIFIC OFFICER | -10.00K | $35.00 | -$350.00K | SELL | -35.31% | 18.32K | Jul 14 | View |
| Jul 16, 2021 | Lee Kalowski Attorney-in-Fact | CHIEF EXECUTIVE OFFICER | 0.00 | $24.14 | -$457.73K | SELL-OPTIONS | 0.00% | 245.09K | Jul 15 - Jul 16 | View |
| Jul 15, 2021 | Kate Bingham | DIRECTOR | -44.90K | $34.00 | -$1.53M | SELL | -53.70% | 38.71K | Jul 13 - Jul 14 | View |
| Jul 14, 2021 | Nigel Crockett | CHIEF BUSINESS OFFICER | 0.00 | $22.11 | -$1.64M | SELL-OPTIONS | 0.00% | 0.00 | Jul 12 - Jul 13 | View |
| Jul 14, 2021 | Lee Kalowski Attorney-in-Fact | CHIEF EXECUTIVE OFFICER | -9.65K | $23.65 | -$1.20M | SELL | -3.79% | 245.09K | Jul 12 - Jul 14 | View |
| Jul 08, 2021 | Nigel Crockett | CHIEF BUSINESS OFFICER | 0.00 | $20.91 | -$6.01K | SELL-OPTIONS | 0.00% | 0.00 | Jul 06 | View |
| May 10, 2021 | Lee Kalowski Attorney-in-Fact | CHIEF EXECUTIVE OFFICER | 0.00 | $23.10 | -$133.29K | SELL-OPTIONS | 0.00% | 254.73K | May 06 - May 07 | View |
| May 05, 2021 | Lee Kalowski Attorney-in-Fact | CHIEF EXECUTIVE OFFICER | 0.00 | $23.07 | -$77.75K | SELL-OPTIONS | 0.00% | 254.73K | May 03 - May 04 | View |
| Apr 30, 2021 | Lee Kalowski Attorney-in-Fact | CHIEF EXECUTIVE OFFICER | 0.00 | $22.43 | -$993.12K | SELL-OPTIONS | 0.00% | 254.73K | Apr 28 - Apr 30 | View |
| Apr 28, 2021 | Lee Kalowski Attorney-in-Fact | CHIEF EXECUTIVE OFFICER | -4.07K | $22.56 | -$489.34K | SELL | -1.57% | 254.73K | Apr 26 - Apr 27 | View |
| Apr 09, 2021 | Pierre Legault | DIRECTOR | 0.00 | $20.22 | -$570.50K | SELL-OPTIONS | 0.00% | 0.00 | Apr 08 | View |
| Apr 07, 2021 | Pierre Legault | DIRECTOR | 0.00 | $19.95 | -$3.60K | SELL-OPTIONS | 0.00% | 0.00 | Apr 05 | View |
| Apr 02, 2021 | Nicholas Keen | CHIEF SCIENTIFIC OFFICER | -10.00K | $30.00 | -$300.00K | SELL | -26.10% | 28.32K | Mar 31 | View |
| Apr 02, 2021 | Pierre Legault | DIRECTOR | 0.00 | $19.39 | -$212.20K | SELL-OPTIONS | 0.00% | 0.00 | Mar 31 | View |
| Mar 19, 2021 | Pierre Legault | DIRECTOR | 0.00 | $18.93 | -$156.85K | SELL-OPTIONS | 0.00% | 0.00 | Mar 17 | View |
| Mar 16, 2021 | Pierre Legault | DIRECTOR | 0.00 | $18.93 | -$44.63K | SELL-OPTIONS | 0.00% | 0.00 | Mar 12 | View |
| Mar 16, 2021 | Nicholas Keen | CHIEF SCIENTIFIC OFFICER | -10.00K | $28.48 | -$284.84K | SELL | -20.69% | 38.32K | Mar 12 - Mar 15 | View |
| Feb 09, 2021 | Lee Kalowski Attorney-in-Fact | CHIEF EXECUTIVE OFFICER | -100.00 | $31.00 | -$3.10K | SELL | -0.04% | 258.80K | Feb 05 | View |
| Jan 21, 2021 | Lee Kalowski Attorney-in-Fact | CHIEF EXECUTIVE OFFICER | -6.18K | $29.76 | -$184.07K | SELL | -2.33% | 258.90K | Jan 19 - Jan 20 | View |
| Jan 21, 2021 | Lee Kalowski | PRESIDENT AND CFO | 0.00 | $15.79 | -$426.15K | SELL-OPTIONS | 0.00% | 0.00 | Jan 19 | View |
| Jan 15, 2021 | Lee Kalowski | PRESIDENT AND CFO | 0.00 | $13.30 | -$234.00K | SELL-OPTIONS | 0.00% | 0.00 | Jan 14 | View |
| Jan 15, 2021 | Lee Kalowski as Attorney-in-Fact | CHIEF EXECUTIVE OFFICER | -10.00K | $26.00 | -$260.05K | SELL | -3.64% | 265.08K | Jan 14 - Jan 15 | View |
| Dec 03, 2020 | Lee Kalowski | — | 0.00 | $12.03 | -$157.05K | OPTION EXERCISE | 0.00% | 0.00 | Dec 01 | View |
| Nov 30, 2020 | Lee Kalowski | — | 0.00 | $10.78 | -$9.77K | OPTION EXERCISE | 0.00% | 0.00 | Nov 27 | View |
| Nov 25, 2020 | Lee Kalowski | — | 0.00 | $10.74 | -$495.04K | OPTION EXERCISE | 0.00% | 0.00 | Nov 23 - Nov 25 | View |
| Sep 18, 2020 | PLC GLAXOSMITHKLINE | — | -4.74K | $19.36 | -$91.83K | SELL | -0.25% | 1.91M | Jul 14 - Jul 15 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
BCYC Insider Trading News
No news found